Peak period of ascites after fresh embryo transfer

In daily life, many couples need to use artificial induction of pregnancy due to infertility. Many people choose to do in vitro fertilization, and the actual effect is relatively good. When doing in vitro fertilization, ovulation-stimulating drugs are needed to select cost-effective eggs, and then artificial in vitro fertilization egg retrieval will cause ascites. However, the symptoms of ascites after fresh embryo test tube transplantation must be taken seriously.

It is very common for ascites to occur after egg retrieval for in vitro fertilization. Its main manifestations are abdominal distension, enlarged abdominal circumference of the fetus, and decreased appetite. It will take about a month to recover, so there is no need to worry too much. Patients with mild ascites need to pay attention to rest and can generally be cured. It is necessary to prevent medication from affecting the physical and mental health of the fetus. After fresh embryo transfer and egg retrieval, in vitro fertilization should be done at an appropriate time.

If the condition of ascites is serious, medication should be used to treat the symptoms, and some symptomatic Chinese herbal medicines can be used for treatment. The phenomenon of ascites after IVF egg retrieval is quite common. If you experience this discomfort, it is recommended to eat some protein-rich foods, such as boiled eggs, winter melon soup, melon and other diuretic foods, which can help alleviate the symptoms of ascites.

If ascites occurs after fresh embryo transplantation, remember to drink plenty of water, which is the most basic solution. It is recommended to wait three days after fresh embryo test tube transfer before going back to work, and be careful not to be overly tired after work, but also not to have too much work pressure. Too much mental stress is actually bad for pregnancy.

Peak period of hepatic ascites after fresh embryo in vitro fertilization

The peak period of ascites after fresh embryo IVF is a serious case of ovarian hyperstimulation syndrome, which often occurs in pregnant patients. The occurrence of ovarian hyperstimulation syndrome is related to the type, dosage, treatment plan of the superovulation drugs commonly used by the patient, the patient's endocrine condition, and whether the patient is pregnant.

Generally speaking, in patients who undergo superovulation, the overall incidence of ovarian hyperstimulation syndrome is about 20%, among which the incidence of moderate to severe cases is 21% to 10%.

Uterine and ovarian hyperstimulation syndrome usually occurs after the use of HCG, because once pregnancy, HCG continues to exist in the body and the symptoms are aggravated. Clinical symptoms may last for 2 to 3 months.